bullish
Mesoblast's Partner Receives Full Approval in Japan; Commercial Launch Ahead
276 Views21 Sep 2015 15:09
Mesoblast's Japanese partner, JCR Pharmaceuticals, has received full approval from the Japanese Ministry of Health, Labour and Welfare for its...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 47-minute read)
Discussions
(Paid Plans Only)
Morningstar, Inc.
Leading Independent Investment Research
Price Chart(Sign Up to Access)
- Raising FVE for Mesoblast After Adjusting for AUD as We Await 180 Day Survival Data in AGvHD13 Jul 2018
- Mesoblast Books First-Half Profit and Moves Closer to FDA Approval in Pediatric AGvHD01 Mar 2018
- Lead Heart Trial Beats Faster for Mesoblast; Interim Analysis Encouraging11 Apr 2017
- Mesoblast's Partner Receives Full Approval in Japan; Commercial Launch Ahead21 Sep 2015
- Major Milestone Ahead for Mesoblast as Japanese Partner Moves Closer to Market with JR-03108 Sep 2015
x